Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...

NEW YORK - Bunge Global SA (NYSE: NYSE:BG) reported fourth quarter earnings that fell short of analyst expectations, sending shares down 3.76% in early trading Wednesday.